It is currently Tue Mar 28, 2017 2:08 am

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Adding "industry leaders" to the mix...

Looks nice and international. Hope some of this crew is bringing some cash to the table:

http://www.opexatherapeutics.com/?page= ... cle=080510

Maybe Phase III will run concurrently with some European sites?
Read more : Adding "industry leaders" to the mix... | Views : 2944 | Replies : 0


Letter to Shareholders

http://www.opexatherapeutics.com/?page=release&section=news&article=060710

June 07, 2010 08:30 AM Eastern Daylight Time

To Our Shareholders,

As we approach the mid-point of 2010, I wanted to take the opportunity to provide an update on our activities and progress - beyond our quarterly filings and periodic press releases. Let me say at the outset that the vision for Opexa remains the same – to bring to market what we believe is one of the most promising treatments for Multiple Sclerosis ...
Read more : Letter to Shareholders | Views : 3083 | Replies : 1




Opexa Strengthens Management Team

Don't know how it effects us, but thought I would post.

<shortened url>
Read more : Opexa Strengthens Management Team | Views : 2868 | Replies : 1


Opexa presentation.

<shortened url>

I hope this helps!
Read more : Opexa presentation. | Views : 3118 | Replies : 2


Opexa to present at AAN 2010

..
Read more : Opexa to present at AAN 2010 | Views : 3050 | Replies : 1


.

.
Read more : . | Views : 3036 | Replies : 1


Opexa presentation

.
Read more : Opexa presentation | Views : 3333 | Replies : 1


Has Opexa restarted Clinical Trials anywhere?

Does anyone have any information about Opexa restarting the Tovaxin clinical trials anywhere?
Read more : Has Opexa restarted Clinical Trials anywhere? | Views : 4075 | Replies : 10


Opexa News

This is somewhat old news, but I don't think it's been posted previously.

Opexa Triggers Milestone Payment Under Recently Announced Stem Cell Agreement

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company’s recently announced exclusive stem cell agreement with Novartis, one of the world’s largest healthcare companies. The milestone ...
Read more : Opexa News | Views : 3999 | Replies : 6


 

Login  •  Register


Statistics

Total posts 237122 • Total topics 25721 • Total members 17009


Contact us | Terms of Service